Timothy J. Scannell's Insider Trades & SAST Disclosures
Timothy J. Scannell's most recent trade in Masimo Corp was a trade of 1,383 Restricted Stock Units done . Disclosure was reported to the exchange on Oct. 16, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Timothy J. Scannell.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Masimo Corp | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Oct 2024 | 1,383 | 1,383 | - | - | Restricted Stock Units | |
| Insulet Corporation | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 225.84 per share. | 10 Sep 2024 | 5,000 | 30,586 (0%) | 0% | 225.8 | 1,129,200 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 190.51 per share. | 10 Jun 2024 | 7,000 | 35,586 (0%) | 0% | 190.5 | 1,333,570 | Common Stock |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 6,229 | 6,229 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 4,053 | 7,981 | - | 0 | Restricted Stock Units | |
| NovoCure Ltd | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 04 Jun 2024 | 964 | 2,964 (0%) | 0% | 23.9 | 23,027 | Ordinary Shares |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 5,525 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.37 per share. | 28 May 2024 | 5,525 | 37,064 (0%) | 0% | 27.4 | 151,219 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 5,235 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.87 per share. | 28 May 2024 | 5,235 | 42,299 (0%) | 0% | 28.9 | 151,134 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.38 per share. | 28 May 2024 | 3,920 | 31,539 (0%) | 0% | 36.4 | 142,610 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,920 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2024 | 3,587 | 0 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Timothy John Scannell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.60 per share. | 28 May 2024 | 3,587 | 45,886 (0%) | 0% | 40.6 | 145,632 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Sale of securities on an exchange or to another person at price $ 180.90 per share. | 28 May 2024 | 3,300 | 42,586 (0%) | 0% | 180.9 | 596,970 | Common Stock |
| Insulet Corporation | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 1,380 | 27,619 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 6,277 | 6,277 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,853 | 3,928 | - | 0 | Restricted Stock Units | |
| Insulet Corporation | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 843 | 26,239 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 8,700 | 8,700 | - | - | Options to Buy Ordinary Shares | |
| Molekule Group Inc | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 55,289 | 55,289 | - | - | Restricted Stock Units | |
| Insulet Corporation | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 1,009 | 25,396 (0%) | 0% | 0 | Common Stock | |
| Molekule Group Inc | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 37,000 | 37,000 | - | - | Restricted Stock Units | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 3,659 | 0 | - | - | Restricted Stock Units granted 07/09/2018 | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2021 | 3,659 | 221,579 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.94 per share. | 01 Aug 2021 | 1,872 | 219,707 (0%) | 0% | 270.9 | 507,200 | Common Stock |
| Insulet Corporation | Timothy J. Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 808 | 24,387 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2021 | 8,268 | 221,866 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 230.00 per share. | 21 Mar 2021 | 3,946 | 217,920 (0%) | 0% | 230 | 907,580 | Common Stock |
| NovoCure Ltd | Timothy J. Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2021 | 7,929 | 7,929 | - | - | Options to Buy Ordinary Shares | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 63,795 | 63,795 | - | - | Employee Stock Option granted 02/03/2021 (right to buy) | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 62,490 | 0 | - | - | Employee Stock Option granted 02/13/2013 (right to buy) | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.01 per share. | 23 Nov 2020 | 62,490 | 258,954 (0%) | 0% | 64.0 | 3,999,985 | Common Stock |
| Stryker Corp. | Timothy J. Scannell | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.86 per share. | 23 Nov 2020 | 40,356 | 218,598 (0%) | 0% | 232.9 | 9,397,298 | Common Stock |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 36,100 | 0 | - | - | Employee Stock Option granted 02/21/2012 (right to buy) | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.60 per share. | 23 Nov 2020 | 36,100 | 218,989 (0%) | 0% | 53.6 | 1,934,960 | Common Stock |
| Stryker Corp. | Timothy J. Scannell | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 232.86 per share. | 23 Nov 2020 | 22,525 | 196,464 (0%) | 0% | 232.9 | 5,245,172 | Common Stock |
| Stryker Corp. | Timothy J. Scannell | President and COO | Sale of securities on an exchange or to another person at price $ 232.61 per share. | 23 Nov 2020 | 5,000 | 213,598 (0%) | 0% | 232.6 | 1,163,038 | Common Stock |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 3,659 | 184,759 (0%) | 0% | 0 | Common Stock | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2020 | 3,659 | 3,659 | - | - | Restricted Stock Units granted 07/09/2018 | |
| Stryker Corp. | Timothy J. Scannell | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 193.30 per share. | 01 Aug 2020 | 1,872 | 182,887 (0%) | 0% | 193.3 | 361,858 | Common Stock |
| Insulet Corporation | Timothy J. Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,029 | 23,579 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges